Inactive C-terminal telomerase reverse transcriptase insertion splicing variants are dominant-negative inhibitors of telomerase

作者: Shusen Zhu , Philippe Rousseau , Catherine Lauzon , Valentina Gandin , Ivan Topisirovic

DOI: 10.1016/J.BIOCHI.2013.12.023

关键词:

摘要: Maintenance of telomere length and structure is essential for cell survival. Telomere synthesis mediated by the ribonucleoprotein telomerase in 90% cancer cells, regulated mainly transcription human reverse transcriptase subunit, hTERT. However, transcriptome analysis reveals complex splicing patterns to date, twenty-two alternatively-spliced hTERT mRNAs have been reported, yet their functions not fully elucidated. The best characterized spliced variants encode inactive proteins that possess specific deletions within catalytic domains. We studied two less well splice (termed INS3 4) with intact motifs, but alternative C-domains due insertion intronic sequences. determined prevalence these mRNA primary telomerase-positive cells lengthening (ALT) found transcripts be expressed lines translated into as illustrated association polysomes. These were when vitro or retained DNA substrate binding impaired RNA component in, immunoprecipitated from either telomerase-negative ALT coexpressing component. Stable expression INS4 a hepatocarcinoma line inhibited activity, shortened telomeres slowed growth suggesting potential dominant-negative function.

参考文章(61)
William C. Hahn, Sheila A. Stewart, Mary W. Brooks, Shoshana G. York, Elinor Eaton, Akiko Kurachi, Roderick L. Beijersbergen, Joan H.M. Knoll, Matthew Meyerson, Robert A. Weinberg, Inhibition of telomerase limits the growth of human cancer cells Nature Medicine. ,vol. 5, pp. 1164- 1170 ,(1999) , 10.1038/13495
Melissa A. Dunham, Axel A. Neumann, Clare L. Fasching, Roger R. Reddel, Telomere maintenance by recombination in human cells Nature Genetics. ,vol. 26, pp. 447- 450 ,(2000) , 10.1038/82586
T. M. Bryan, A. Englezou, J. Gupta, S. Bacchetti, R. R. Reddel, Telomere elongation in immortal human cells without detectable telomerase activity. The EMBO Journal. ,vol. 14, pp. 4240- 4248 ,(1995) , 10.1002/J.1460-2075.1995.TB00098.X
Lisa F. Lincz, Lisa-Maree Mudge, Fiona E. Scorgie, Jennette A. Sakoff, Christopher S. Hamilton, Michael Seldon, Quantification of hTERT Splice Variants in Melanoma by SYBR Green Real-time Polymerase Chain Reaction Indicates a Negative Regulatory Role for the β Deletion Variant Neoplasia. ,vol. 10, pp. 1131- 1137 ,(2008) , 10.1593/NEO.08644
Linda C. Giudice, Andrew R. Hoffman, Thanh H. Vu, Ji-Fan Hu, Gary A. Ulaner, Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts Cancer Research. ,vol. 58, pp. 4168- 4172 ,(1998)
Y. D'Souza, C. Lauzon, T. W. Chu, C. Autexier, Regulation of telomere length and homeostasis by telomerase enzyme processivity. Journal of Cell Science. ,vol. 126, pp. 676- 687 ,(2012) , 10.1242/JCS.119297
S.W. Knight, N.S. Heiss, T.J. Vulliamy, S. Greschner, G. Stavrides, G.S. Pai, G. Lestringant, N. Varma, P.J. Mason, I. Dokal, A. Poustka, X-Linked Dyskeratosis Congenita Is Predominantly Caused by Missense Mutations in the DKC1 Gene American Journal of Human Genetics. ,vol. 65, pp. 50- 58 ,(1999) , 10.1086/302446
Takashi Yamane, Keiko Miyano, Kazuhisa Taketa, Jiro Sato, Hidekazu Nakabayashi, Growth of human hepatoma cell lines with differentiated functions in chemically defined medium Cancer Research. ,vol. 42, pp. 3858- 3863 ,(1982)
Sarah C P Williams, No end in sight for telomerase-targeted cancer drugs Nature Medicine. ,vol. 19, pp. 6- 6 ,(2013) , 10.1038/NM0113-6